ACTIVE

ReWrite

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-17,9 k €
Gross margin
64 k €
Equity
-2,9 k €

What does ReWrite do?

ReWrite is a Private limited company incorporated in 2024. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 1016.891.283
Incorporation
03/12/2024
Legal form
Private limited company
Registered office
Gaston Geenslaan 1
3001 Leuven · FlandreSee on map
Contributed capital
15 000,00 €
Latest accounts
31/12/2025
Activities (NACE)
72101Research and experimental development on natural sciences and engineering· main74999Other professional, scientific and technical activities n.e.c.62900Computer programming, consultancy and related activities70200Management consultancy activities72109Research and experimental development on natural sciences and engineering
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 1 financial year

2025
Income statement
Gross margin64 k €
EBITDA-14,4 k €
Operating result-19,4 k €
Net result-17,9 k €
Balance sheet
Equity-2,9 k €
Total assets115,4 k €
Cash44,1 k €
Debts118,2 k €
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active

Active mandates

Fatemeharefeh Nami

Mandate

Active
At this address

Other companies at this address

CompanyCBE no.
ALIGOS BELGIUM● Active
0702.969.886
Bio-Incubator Leuven● Active
0876.605.232
Community Building Arenberg● Active
1014.096.594
Creative Biolabs Belgium● Active
1028.942.544
DName-iT● Active
0506.754.823
Fisherman● Active
0804.287.079
Fishway● Active
0787.869.632
Formac Pharmaceuticals● Active
0892.914.395
IDA INTERNATIONAL● Active
1002.119.470
Lever Bio Belgium● Active
1039.455.958
Maatschap reMYND● Active
1019.655.090
miDiagnostics● Active
0641.984.602
Oxurion● Active
0881.620.924
PALEO● Active
0756.986.614
PARKEERGEBOUW● Active
1009.039.728
Pledge Therapeutics● Active
0726.743.301
Qmineral● Active
0837.633.897
Raya Therapeutic● Active
1003.128.171
ReGenesys● Active
0877.070.337
ReGenesys EU● Active
0544.577.301
Annual accounts

Full financial information

2025
Type of accountMicro model
Start of the financial year03/12/2024
Closing of the financial year31/12/2025
Length of the financial year13 months
Filing date31/08/2026
General meeting30/06/2026
Currency of the financial yearEUR
NBB quality labelSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

1 filing with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202530/06/202631/08/2026DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active

Active mandates

Fatemeharefeh Nami

Mandate

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office18/02/2026
    Wijziging maatschappelijke zetel
    PDF
  • Other05/12/2024
    OPRICHTING
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-17,9 k €
  2. 03/12/2024
    IncorporationPrivate limited company